{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:15:44Z","timestamp":1790392544662,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.pharma.2009.01.001","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T04:48:38Z","timestamp":1236314918000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neuropathologie morphologique et mol\u00e9culaire de la maladie d\u2019Alzheimer"],"prefix":"10.1016","volume":"67","author":[{"given":"C.","family":"Duyckaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Delatour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Potier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2009.01.001_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/197192b0","article-title":"Paired helical filaments in electron microscopy in Alzheimer's disease","volume":"197","author":"Kidd","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2009.01.001_bib2","first-page":"229","article-title":"Mise en \u00e9vidence immunologique de la prot\u00e9ine tau au niveau des l\u00e9sions de d\u00e9g\u00e9n\u00e9rescence neurofibrillaire de la maladie d\u2019Alzheimer","volume":"95","author":"Brion","year":"1985","journal-title":"Arch Biol (Brux)"},{"key":"10.1016\/j.pharma.2009.01.001_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00308912","article-title":"Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins","volume":"80","author":"Delacourte","year":"1990","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","article-title":"Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein Tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain","volume":"8","author":"Goedert","year":"1989","journal-title":"Embo J"},{"key":"10.1016\/j.pharma.2009.01.001_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2990.1988.tb00864.x","article-title":"Neuropil threads occur in dendrites of tangle-bearing nerve cells","volume":"14","author":"Braak","year":"1988","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharma.2009.01.001_bib6","first-page":"352","article-title":"Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque, neurites and neuropil threads","volume":"64","author":"Schmidt","year":"1991","journal-title":"Lab Invest"},{"key":"10.1016\/j.pharma.2009.01.001_bib7","first-page":"643","article-title":"\u00c9tude histochimique des plaques s\u00e9niles","volume":"9","author":"Divry","year":"1927","journal-title":"J Belge Neurol Psych"},{"key":"10.1016\/j.pharma.2009.01.001_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","article-title":"Amyloid deposits and amyloidosis. The \u00df-fibrilloses","volume":"302","author":"Glenner","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2009.01.001_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharma.2009.01.001_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2009.01.001_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/353844a0","article-title":"Early-onset Alzheimer's disease caused by mutations at codon 717 of the \u00df-amyloid precursor protein gene","volume":"353","author":"Chartier-Harlin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2009.01.001_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharma.2009.01.001_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncb960","article-title":"Reconstitution of gamma-secretase activity","volume":"5","author":"Edbauer","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharma.2009.01.001_bib14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/sj.emboj.7601616","article-title":"GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42","volume":"26","author":"Munter","year":"2007","journal-title":"Embo J"},{"key":"10.1016\/j.pharma.2009.01.001_bib15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","article-title":"Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach","volume":"85","author":"Sergeant","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2009.01.001_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00305876","article-title":"Subtypes and differential laminar distributions of \u00dfA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases","volume":"81","author":"Dela\u00e8re","year":"1991","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0197-4580(02)00134-3","article-title":"A grading system of Alzheimer disease lesions in neocortical areas","volume":"24","author":"Metsaars","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0197-4580(00)00094-4","article-title":"Microglia, amyloid and dementia in Alzheimer disease. A correlative study","volume":"21","author":"Arends","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s004010000199","article-title":"Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation","volume":"100","author":"Wegiel","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2009.01.001_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","article-title":"A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide: the first step of a fatal cascade","volume":"91","author":"Wirths","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2009.01.001_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0191-4","article-title":"Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration","volume":"113","author":"Wegiel","year":"2007","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-005-1053-1","article-title":"Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner","volume":"110","author":"Thal","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharma.2009.01.001_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib26","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of Abeta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2009.01.001_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharma.2009.01.001_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s004010050816","article-title":"Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease","volume":"95","author":"Grignon","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00309621","article-title":"Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease","volume":"89","author":"Cras","year":"1995","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib30","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0197-4580(98)00042-6","article-title":"Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease","volume":"19","author":"Cotman","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0002-9440(10)65460-0","article-title":"Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death","volume":"155","author":"Stadelmann","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9440(10)63957-0","article-title":"Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease","volume":"158","author":"Rohn","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib33","first-page":"731","article-title":"The cell division cycle and the pathophysiology of Alzheimer's disease","volume":"87","author":"Nagy","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharma.2009.01.001_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s004010050818","article-title":"Laminar spongiosis of the dentate gyrus: a sign of disconnection, present in cases of Alzheimer disease","volume":"95","author":"Duyckaerts","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib35","series-title":"Alzheimer disease","first-page":"179","article-title":"Structural basis of the cognitive alterations in Alzheimer disease","author":"Terry","year":"1994"},{"key":"10.1016\/j.pharma.2009.01.001_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2006-9S312","article-title":"Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus","volume":"9","author":"Scheff","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharma.2009.01.001_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(89)90582-X","article-title":"Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease","volume":"103","author":"Masliah","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharma.2009.01.001_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/bbrc.1997.6940","article-title":"Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease","volume":"236","author":"Shimohama","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharma.2009.01.001_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-4580(95)00013-5","article-title":"Correlations of synaptic and pathological markers with cognition of the elderly","volume":"16","author":"Dickson","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.1998.6863","article-title":"Evidence for synaptic apoptosis","volume":"153","author":"Mattson","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharma.2009.01.001_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0197-4580(97)80306-5","article-title":"Modeling the relation between neurofibrillary tangles and intellectual status","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0197-4580(97)00047-X","article-title":"Prevalence, incidence and duration of Braak's stages in the general population: can we know?","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib44","doi-asserted-by":"crossref","unstructured":"Neuropathology group of the medical research council cognitive function and ageing study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169\u201375.","DOI":"10.1016\/S0140-6736(00)03589-3"},{"key":"10.1016\/j.pharma.2009.01.001_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0312-8","article-title":"Alzheimer disease models and human neuropathology: similarities and differences","volume":"115","author":"Duyckaerts","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2009.01.001_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","article-title":"Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model","volume":"165","author":"Casas","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","article-title":"Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models","volume":"16","author":"Herzig","year":"2006","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pharma.2009.01.001_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","article-title":"Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2009.01.001_bib50","first-page":"2866","article-title":"Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy","volume":"27","author":"Farris","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharma.2009.01.001_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2009.01.001_bib52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition","volume":"17","author":"Van Dam","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharma.2009.01.001_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","article-title":"Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes","volume":"1017","author":"Howlett","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharma.2009.01.001_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neurobiolaging.2006.01.004","article-title":"Intact spatial learning in adult Tg2576 mice","volume":"28","author":"Bizon","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib55","article-title":"Impairment of spatial memory consolidation in APP(751SL) mice results in cue-guided response","author":"Blanchard","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2009.01.001_bib56","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","article-title":"Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models","volume":"282","author":"Cheng","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharma.2009.01.001_bib57","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharma.2009.01.001_bib58","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pharma.2009.01.001_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2009.01.001_bib60","series-title":"Alzheimer's disease and related disorders. Annual 2004","first-page":"1","article-title":"The innervation of senile plaques: a link between amyloid and neurofibrillary pathology?","author":"Delatour","year":"2003"},{"key":"10.1016\/j.pharma.2009.01.001_bib61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharma.2009.01.001_bib62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s004010051148","article-title":"Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein","volume":"99","author":"Probst","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.pharma.2009.01.001_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1051\/medsci\/2007232180","article-title":"Animal models of neurodegenerative diseases","volume":"23","author":"Langui","year":"2007","journal-title":"Med Sci (Paris)"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450909000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450909000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:27:30Z","timestamp":1757719650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450909000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0003450909000054"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2009.01.001","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathologie morphologique et mol\u00e9culaire de la maladie d\u2019Alzheimer","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2009.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}